PMS30 Cost-Effectiveness of Tocilizumab Compared to Standard Therapeutic Sequences for the Treatment of Moderate/Severe Rheumatoid Arthritis (RA) Patients in Portugal
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.416
https://www.valueinhealthjournal.com/article/S1098-3015(11)01978-4/fulltext
Title :
PMS30 Cost-Effectiveness of Tocilizumab Compared to Standard Therapeutic Sequences for the Treatment of Moderate/Severe Rheumatoid Arthritis (RA) Patients in Portugal
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01978-4&doi=10.1016/j.jval.2011.08.416
First page :
A307
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
389